The partnership between Lantern and Pelago represents a transformative approach to addressing substance use disorders (SUDs), a critical and growing concern among the U.S. workforce. With 49 million adults affected by SUD or mental health illness, and only a fraction receiving adequate employer support, this collaboration bridges a significant healthcare gap. By combining Lantern’s specialty care expertise with Pelago’s innovative substance use treatment, employers can now provide their teams with personalized, effective care, resulting in better health outcomes and enhanced workforce well-being.